Sarepta Therapeutics Appoints Michael Severino CEO, Effective July 28, Succeeding Doug Ingram
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the appointment of Michael Severino, M.D., as chief executive officer, effective July 28, 2026.
Sarepta is getting a new leader starting July 28—Michael Severino will be the boss instead of Doug Ingram. When a company changes its top leader, watch how the company does over the next year to see if the new person's ideas work well.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.